Literature DB >> 21549178

A miR-centric view of head and neck cancers.

Janki Mohan Babu1, R Prathibha, V S Jijith, Ramkumar Hariharan, M Radhakrishna Pillai.   

Abstract

Head and Neck Squamous Cell Carcinomas (HNSCCs) constitute the sixth most common cancer worldwide with an average 5-year survival rate of around 50%. Several microRNAs, small non-coding RNAs involved in post-transcriptional gene regulation, have been linked to HNSCC based on their differential expression in tumors. Here, we present a compilation of multiple types of information on each HNSCC linked miRNA including their expression status in tumors, their molecular targets relevant to cancer, results of gene manipulation studies and association with clinical outcome. Further, we use this information to devise a new scheme for classifying them into causal and non-causal miRNAs in HNSCC. We also discuss the possibility of using miRNAs as prognostic and diagnostic biomarkers for HNSCC, based on existing literature. Finally, we present available evidence that shows how altered expression of specific miRNAs can contribute to various "hallmarks of cancer" phenotypes such as limitless replicative potential owing to abnormal cell cycle regulation, evasion of apoptosis, reduced response to anti-growth signals, and Epithelial-Mesechymal transition (EMT). 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549178     DOI: 10.1016/j.bbcan.2011.04.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

1.  MiR-21/miR-375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma.

Authors:  An Hu; Jing-Juan Huang; Wei-Hua Xu; Xiao-Jie Jin; Ji-Ping Li; Yuan-Jia Tang; Xin-Fang Huang; Hui-Juan Cui; Guang-Bin Sun; Rui-Lin Li; Jun-Li Duan
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 2.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

3.  An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.

Authors:  Francesca Citron; Joshua Armenia; Giovanni Franchin; Jerry Polesel; Renato Talamini; Sara D'Andrea; Sandro Sulfaro; Carlo M Croce; William Klement; David Otasek; Chiara Pastrello; Tomas Tokar; Igor Jurisica; Deborah French; Riccardo Bomben; Emanuela Vaccher; Diego Serraino; Barbara Belletti; Andrea Vecchione; Luigi Barzan; Gustavo Baldassarre
Journal:  Clin Cancer Res       Date:  2017-02-07       Impact factor: 12.531

Review 4.  miRNAs in head and neck cancer revisited.

Authors:  Rahul Nagadia; Pratibala Pandit; William B Coman; Justin Cooper-White; Chamindie Punyadeera
Journal:  Cell Oncol (Dordr)       Date:  2013-01-22       Impact factor: 6.730

5.  Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.

Authors:  F Ganci; A Sacconi; N Bossel Ben-Moshe; V Manciocco; I Sperduti; L Strigari; R Covello; M Benevolo; E Pescarmona; E Domany; P Muti; S Strano; G Spriano; G Fontemaggi; G Blandino
Journal:  Ann Oncol       Date:  2013-10-09       Impact factor: 32.976

Review 6.  [Cancer stem cell phenotypes and miRNA: therapeutic targets in head and neck squamous cell carcinoma].

Authors:  A Coordes; S Zhifeng; V Sangvatanakul; X Qian; M Lenarz; A M Kaufmann; A E Albers
Journal:  HNO       Date:  2014-12       Impact factor: 1.284

7.  Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer.

Authors:  Anders Näsman; Mircea Romanitan; Cecilia Nordfors; Nathalie Grün; Hemming Johansson; Lalle Hammarstedt; Linda Marklund; Eva Munck-Wikland; Tina Dalianis; Torbjörn Ramqvist
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

8.  New Concepts for Translational Head and Neck Oncology: Lessons from HPV-Related Oropharyngeal Squamous Cell Carcinomas.

Authors:  Efterpi Kostareli; Dana Holzinger; Jochen Hess
Journal:  Front Oncol       Date:  2012-04-11       Impact factor: 6.244

9.  miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.

Authors:  Francesca Citron; Ilenia Segatto; Lorena Musco; Ilenia Pellarin; Gian Luca Rampioni Vinciguerra; Giovanni Franchin; Giuseppe Fanetti; Francesco Miccichè; Vittorio Giacomarra; Valentina Lupato; Andrea Favero; Isabella Concina; Sanjana Srinivasan; Michele Avanzo; Isabella Castiglioni; Luigi Barzan; Sandro Sulfaro; Gianluigi Petrone; Andrea Viale; Giulio F Draetta; Andrea Vecchione; Barbara Belletti; Gustavo Baldassarre
Journal:  EMBO Mol Med       Date:  2021-06-01       Impact factor: 12.137

10.  Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.

Authors:  Isolde Summerer; Julia Hess; Adriana Pitea; Kristian Unger; Ludwig Hieber; Martin Selmansberger; Kirsten Lauber; Horst Zitzelsberger
Journal:  BMC Genomics       Date:  2015-09-02       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.